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Summary: The effects of administration of ambilhar to rats poisoned with mercury for two weeks were investigated.
The results showed that administration of ambilhar to rats dosed with mercuric Chloride, resulted in a significant
increase in the faecal excretion of mercury. At the same time a significant decrease in the urinary Output of the metal
was found. Chelation of ambilhar with mercury to form a polar complex with a higher molecular weight could
explain its biliary rather than its urinary excretion. The spectral studies of ambilhar and its two mercury complexes
prepared in vitro support the possibility that Stimulation of mercury excretion in bile results from the complexation
of mercury by ambilhar in vivo.
Wirkung von Ambilhar auf die Mobilisierung von Quecksilber und seine Ausscheidung mit der Galle
Zusammenfassung: Die Wirkung von Ambilhar auf Ratten, die zwei Wochen lang eine Quecksilberchlorid enthal-
tende Diät erhielten, wurde untersucht. Die Behandlung mit Ambilhar bewirkte einen signifikanten Anstieg der
Quecksilberausscheidung in den Faeces, Gleichzeitig fiel die Ausscheidung von Quecksilber im Harn. Die Chelatbil-
dung von Quecksilber mit Ambilhar zu einem polaren Komplex mit höherem Molekulargewicht könnte die bevor-
zugte Ausscheidung über die Galle gegenüber der mit dem Harn erklären. Spektrophotometrische Untersuchungen
von Ambilhar und seiner zwei in vitro präparierten Quecksilberkomplexe unterstützen die Möglichkeit, daß die
Quecksilberausscheidung mit der Galle durch Komplexbildung von Quecksilber mit Ambilhar in vivo gefördert wird.
Introduction
Earlier studies on the antibilharzial drug ambilhar
revealed its metal ligating ability. Salah et al. (1) and
Abdel Aziz et al. (2) demonstrated the excretion of
iron in the urine of man and animals after administra-
tion öf the drug.
Similar effects of ambilhär on body calciuin and magne-
sium (3) and lead excretion (4) were reporteil·. The
latter finding on lead excretion was explained by the .
formation of lead-ambilhar complex in vivo, which
resulted in lead mobilisation and excretion,.
An ideal selective antidote for mercury poisoning has
not yet been found. D,L-penicillamine and its Nracetyl
derivative and dimercapto-propanol (BAL) form stable
complexes with mercury. Most of these antidotes are
toxic and still need more clinical evaluation. (5)
Our present study deals with the formation of rnercury-
ambilhar complexes in vitro. In addition, the ability of
this drug to stimulate mercury excretion was investi-
gated.
Materials and Methods
In vivo investigations
Eight Wistar albino rats, average body weight 200-250 g, were
used in this study. They were fed a commercial diet prepared in
the College animal house. They were divided into 4 equal groups
in 4 metabolic cages.
Mercury poisoning
Mercuric Chloride was mixed in a mortar with two kilograms of
the diet, so that each gram of the diet contained 0.1 mg mercury.
Rats were fed this diet for a period of two weeks. The daily
dose of mercury for each animal was calculated to be between
1.5 and two mg. Each day the urine äs well äs the faecal excre-
tion of each group was separately collected for mercury estima-
tion.
Administration of ambilhar after mercury poisoning
Ambilhar (niridazole or nitrothiazole) was mixed with two
kilograms of the same diet in the animal house, so that each
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gram contained about 0.5 mg of thc drug. Administration of
this was continued for 14 days starting just after the last day of
mercury poisoning of the same groups of animals. The urine and
faecal matter of cach groups was separately collected for mercury
estimation.
Estimation ofthe mercury content ofthe collected samples
A suitable weight of the dried faecal matter (5 g) of each group
was mixed witli 10 ml 500 g/kg nitric acid (Analar), gently
heated over a small flame until foaming ceased, then gently
boiled for about 30 minutes. The solution was left for 24 hours
at 4 °C and filtered to produce a clear extract, which was used
for analysis. Estimation ofthe mercury content ofthe clear
urine äs well äs the faecal extracts was performed using the
Atomic Absorption Spectrophotometer (Varian Techtron AA-5).
All measurements were made with the most sensitive known
line of the metal, using a hollow cathode lamp and an R 213
photomultiplier. Aqueous Solutions were used together with
the appropriate recommended fuel support combination and
burner. Wavelength was 253.65 nm, slit width 10.0 nm, lamp
current 3 mA.
Sensitivity of the Techtron AA-5 is 2 mg/1. The flame fuel is air
acetylene mixture. A Standard calibration curve was prepared,
using Standard mercuric nitrate solution (100 mg/1). A linear
Standard curve with the concentrations of 2.5, 5,10,15, 20, 30,
40 mg/1 Hg respectively was obtained. The concentrations of
mercury in all samples were calculated according t o the adjusted
conditions and operational procedure of the machine. The
mercury content of Solutions was determined by first spraying
the solution into a flame. then measuring the mercury vapour
in the exhaust gases with the Techtron mercury vapour meter.
Preparation ofambilhar mercury complexes in vitro
One mmol pure crystalline ambilhar (Ciba-Geigy Labs.) was
mixed with one mmol mercury (HgCla), 2 mmol sodium meta-
bisulphite and one mmol sodium hydrogencarbonate. The
whole mixture was pulverized in a mortar, suspended in 50 ml
distilled water and left at room temperature for 48 hours. The
resulting clear solution was concentrated to about 10 ml in a
boiling water bath and refrigerated for 24 hours. A dark coloured
crystalline compound was precipitated. This was separated by
centrifugation, dissolved in 5 ml distilled water and applied to
an alumina column (2.5 X 15 ml) and eluted with 600 ml/l
ethanol. The eluate was concentrated in a waterbath to about
10 ml and left at room temperature for 24 hours, where a dark
crystalline compound (10 mg) was obtained. An aqueous solu-
tion of this compound was subjected to paper chromatography,
using ethanol, ammonia, water (60 ml + 10 ml + 30 ml), and
methanol, acetic acid, water (60 ml + 10 ml + 30 ml). In both
Systems it migrated äs a single spot with Rf values of 0.8 & 0.9
respectively. The ultraviolet spectrum of an aqueous solution of
this complex was determined and compared with that of
ambilhar. A sample of 8 mg was sent to Alfred Bernhardt Labs.,
West Germany, for determination of mercury and molecular
weight (compound A).
The experiment was repeated using 2 mmol sodium metabi-
sulphite and one mmol ambilhar, but with two mmol mercury
(HgCl2) and two mmol sodium hydrogencarbonate. The whole
mixture was warmed in a water-bath for 20 minutes at 75 °C. A
clear solution was obtained. This was filtered and left at room
temperature for 72 hours. The resulting yellow-crystalüne
compound was dissolved in 25 ml 500 ml/1 ethanol, filtered and
concentrated in a boiling water bath to about 7.5 ml. After
72 hours at room temperature yellow crystalline needles were
deposited, which became dark coloured after 24 hours at the
same temperature. Purity was tested äs for the first complex in
the same solvent Systems; a single spot was observed on the
chromatograms. About 8 mg sample was sent to West Germany
(Alfred Bernhardt Labs) for microanalysis.and determination
of mercury content. Rf values of this complex (Compound B)
in the two Systems were 0.4 & 0.5 respectively.
Results
Table l .demonstrates the effect of administration of
ambilhar on the faecal and urinary excretion of mercury
in rats. A significant increase in faecal excretion of the
metal by the drug was found, reaching a maximurn after
10 days. At the same time a significant decrease in the
urinary excretion of mercury can be obsprved.
Tab. 1. Effects of administration öf ambilhar on the urinary and
faecal excretion of mercury in rats. Means of six different
mercury Contents of each sample, using six different völ-
umes.
Group
of rats
After
3 days
Subsequent
4 days
Subsequent
3 days
Subsequent
4 days
Rats dösed
with mercury
Total
urinary
mercury
(± SD)
(mg)
1.4
± (0.2)
1.2
± (0.12)
1.2
± (0.12)
1.1
± (0.1)
Total
faecal
mercury
(± SD)
(mg)
0.4
± (0.1)
0.4
± (0.1)
0.38
± (0.04)
0.50
± (0.04)
Rats dosed with
ambilhar after njercufy
Total
urinary
mercury
x~(±SD)
(mg)
0.35**
± (0.04)
1.4
± (0.3)
0.8*
± (0.2)
0.40**
± (0.2)
Total
faecal
mercury
(± SD)
(mg)
1.10**
±(0.1)
2.6**
± (0.1)
3.2**
± (0.5)
0.70
± (0.2)
* Significant at 5% level of probabüity.
** Significant at 1% level öf probabiüty.
It is evident from table 2 that ambilhar in älkaline
medium and in the presence of heat and sodium meta-
bisulphite can ligate two mercury atoms per one mol of
drug (B), while at room temperature with a lower con-
centration of Hg, and decreased aläkalinity it ligates only
one atom of mercury (A).
Tab. 2. Mercury content and ambilhar mercury chelation ratio
pf the complexes prepared in vitro. (A & B).
Complex Mercury fraction Chelatiqn ratio
A
B
0.5144*
0.6284*
Ambilhar
molecule
1 :
1 :
Mercury
atom
1
2
* Mercury estimation was performed in West 'Gerrhany (Alfred
Bernhardt Labs).
The absorption spectra of ambilhar and its in vitro
prepared complexes with mercury are shown in figure l.
Discussion
It can be seen from table l that administration of
ambilhar to rats poisoned with mercury resuited in a
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Fig. 1. Ultra violet spectra of ambilhar ( ) and its in vitro
prepaied complexes with mercury A ( ) and B
( ). Disappearance of the peak at 380 nm in the drug
after addition of mercury and the reducing agent (sodium
metabisulphite) indicates the formation of an ambilhar
mercury complex. Involvement of the thiazole ring of the
drug in this chelation is also indicated (380 nm).
significant increase in faecal excretion of the metäl,
with a concomitant decrease in its urinary elimination.
A total of 7.617 mg mercury were excreted in the bile in
two weeks when ambilhar was administered. In the con-
trol animals this value was only l .71 mg. On the other
hand a total of 2.927 mg of mercury were excreted in the
urine in two weeks with administration of the drug. In
the control animals this value was 4.875 mg. These
results show the strong effect of ambilhar äs a stimulant
for mercury excretion in bile via the in testine.
Mobilisation of mercury by ambilhar could be ex-
plained äs the result of the in vivo ligation. The rnercury
ambilhar complexes prepared in vitro (figs. 2,3) and the
ability of the drug to form chelates with other metals
(1-4) support our conclusions. The increase in biliary
excretion of mercury during administrätiori of ambilhar
is supporting evidence for an in vivo chelation of the
drug with the metal, because polar compounds of higher
Hg'
Fig. 2. Proposed chemical structure of the in vitro prepared
ambilhar mercury complex A. It shows that one mol of
ambilhar can ligate one atom of mercury. The fraction
of mercury in this complex is 0.515; the results of
microanalysis showed 0.5144. Evidence was obtained
for the role of thiazolyl sulphur in metal ligation.
r-fi
H2N' NH,
"Hg
Fig. 3. Proposed chemical structure of the in vitro prepared
ambilhar mercury complex B. Heat and increased mer-
cury concentration result in a cleavage of the imidazol-
idinone ring. The fra" ction of mercury in this complex is
0.6306; while microanalysis showed 0.6284.
molecular weight are excreted via the bile rather than
the urine (6). Thus, chelation of ambilhar with mercury
to form a chelate of high molecular weight (more than
400) is followed by its biliary excretion.
The in vitro prepafation of two inercury ambilhar com-
plexes with a fraction of 0.5144 and 0.6284 mercury,
respectively, suggests that two different chelates could
also be formed in vivo.
Disappearance of the peak at 380 nm in ambilhar after
the addition of mercury and sodium metabisulphite
(fig, 1) could be explained by the possible involvement
of the thiazole ring of the drug in the chelation process.
Since the ability of the drug to ligate with mercury in
vitro requires reduction it could be inferred that am-
bilhar is also reduced in vivo before ligation with the
metal (10).
Our observation theref ore suggest the use of ambilhar äs
an antidote for mercury poisoning. It would be safer
than other mercury antidotes and its side effects would
be fewer.
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